HomeATRA • NASDAQ
add
Atara Biotherapeutics Inc
Previous close
$4.99
Day range
$4.95 - $5.35
Year range
$3.92 - $19.15
Market cap
40.56M USD
Avg Volume
393.80K
P/E ratio
1.93
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.60M | -95.13% |
Operating expense | 6.23M | -72.80% |
Net income | -3.41M | 73.17% |
Net profit margin | -213.54 | -451.07% |
Earnings per share | -0.35 | 70.59% |
EBITDA | -4.37M | 60.66% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.48M | -80.04% |
Total assets | 20.24M | -81.45% |
Total liabilities | 58.74M | -71.54% |
Total equity | -38.50M | — |
Shares outstanding | 8.18M | — |
Price to book | -0.95 | — |
Return on assets | -53.74% | — |
Return on capital | 56.66% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -3.41M | 73.17% |
Cash from operations | -5.70M | 76.72% |
Cash from investing | 8.44M | 150.00% |
Cash from financing | -3.00K | 99.09% |
Net change in cash | 2.74M | 112.79% |
Free cash flow | -2.60M | 86.88% |
About
Founded
2012
Headquarters
Website
Employees
14
